FDA Proposes Withdrawal Of Low Blood Pressure Drug
Links shared publicly online about this topic.
- 941total visits
FDA Proposes Withdrawal Of Low Blood Pressure Drug
View full resource at medicalnewstoday.com
Tags: Low Blood Pressure, Drug, FDA
Most Recently Shared on August 17, 2010 at 10:00 pm By:
FDA Proposes Withdrawal Of Low Blood Pressure Drug http://mnt.to/3Htg #cardiovascular
Also Shared By:
FDA relents from midodrine withdrawal plan
physorg.com — “(AP) -- Federal regulators have backed off a plan to remove a Shire PLC low blood-pressure treatment from the market after warning in August that the drug has not been proven effective.” View full resource at physorg.com
Most Recently Shared on September 6, 2010 at 5:04 pm By:
PhysOrg Health News Health News
FDA relents from midodrine withdrawal plan http://tw.physorg.com/202997040
News Briefs: Week of Aug. 16-20 -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “This roundup includes the following news briefs: Illinois Enacts Truth in Advertising Legislation for Health Care Licenses, Latex in Caps Dictates Caution When Giving Novartis Flu Vaccine, AHRQ Seeks Topic Nominations for USPSTF, FDA Proposes Withdrawal of Blood Pressure Drug, FDA Approves Emergency Contraception Drug, and AHRQ Launches Website for Men’s Health.” View full resource at aafp.org
Most Recently Shared on August 19, 2010 at 5:05 am By:
News Briefs: Week of Aug. 16-20: This roundup includes the following news briefs: Illinois Enacts Truth in Adverti... http://bit.ly/cfutNf
FDA warns Maple Grove drug company | StarTribune.com
startribune.com — “The Food and Drug Administration has proposed pulling from the market a low-blood-pressure drug that is made by several drug companies, including Maple Grove-based Upsher-Smith Laboratories” View full resource at startribune.com
Most Recently Shared on August 17, 2010 at 4:55 am By:
FDA warns Maple Grove drug company: Upsher-Smith Laboratories didn't do enough studies on midodrine hydrochloride ... http://bit.ly/dAKIqx
FDA Proposes To Remove Shire Drug From Market - WSJ.com
online.wsj.com — “The FDA proposed to remove from the market a low-blood pressure drug originally developed by Shire, saying required follow-up clinical studies showing the drug works haven't been conducted.” View full resource at online.wsj.com
Most Recently Shared on August 16, 2010 at 8:51 pm By:
FDA Proposes To Remove Shire Drug From Market http://on.wsj.com/aO3U9v
Advertisement
MNT Drug Approvals
@mnt_drugapprov
FDA Proposes Withdrawal Of Low Blood Pressure Drug http://mnt.to/3Htg #regulatory
1 year ago...